A. E. Till
Impact in
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Analytical Methods in Pharmaceuticals 5
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Martin Hichens (4 shared papers)HJ Gomez (3 shared papers)E H Ulm (2 shared papers)Jérôme Biollaz (1 shared paper)Elizabeth L. Hand (1 shared paper)John D. Irvin (3 shared papers)Helen R. Skeggs (3 shared papers)Peter H. Vlasses (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (2 papers)Journal of Pharmaceutical Sciences (1 paper)Cardiovascular Drug Reviews (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
A. E. Till
14 papers receiving 446 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 70
- Analytical Chemistry 80
- Cardiology and Cardiovascular Medicine 169
- Pharmacology 107
- Molecular Medicine 28
Countries citing papers authored by A. E. Till
This map shows the geographic impact of A. E. Till's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Till with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Till more than expected).
Fields of papers citing papers by A. E. Till
This network shows the impact of papers produced by A. E. Till. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Till. The network helps show where A. E. Till may publish in the future.
Co-authors
The 25 scholars most cited alongside A. E. Till, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 193 | |
| 2 | 1984 | 53 | |
| 3 | 1993 | 50 | |
| 4 | 1974 | 43 | |
| 5 | 1985 | 38 | |
| 6 | 1987 | 37 | |
| 7 | 1976 | 22 | |
| 8 | 1989 | 20 | |
| 9 | 1989 | 18 | |
| 10 | 1985 | 18 | |
| 11 | BIOAVAILABILITY OF ENALAPRIL MALEATE | 1984 | 16 |
| 12 | 1979 | 12 | |
| 13 | 1980 | 3 | |
| 14 | 1975 | 2 |
About A. E. Till
A. E. Till is a scholar working on Analytical Chemistry, Pharmacology, Pharmacology, Nutrition and Dietetics and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 525 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Potassium and Related Disorders (3 papers), Protein Hydrolysis and Bioactive Peptides (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Heart Failure Treatment and Management (2 papers) and Pharmaceutical studies and practices (1 paper). The work is most often cited by research in Pharmacology (70 citations), Analytical Chemistry (80 citations), Cardiology and Cardiovascular Medicine (169 citations), Pharmacology (107 citations) and Molecular Medicine (28 citations). A. E. Till has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Martin Hichens, HJ Gomez, E H Ulm, Jérôme Biollaz, Elizabeth L. Hand, John D. Irvin, Helen R. Skeggs, Peter H. Vlasses, Katherine E. Harris and Ralph Ferguson. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Journal of Pharmaceutical Sciences, Cardiovascular Drug Reviews and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.